Comparison of human and mouse stem cells: differences in microRNA regulation
人类和小鼠干细胞的比较:microRNA 调控的差异
基本信息
- 批准号:10338111
- 负责人:
- 金额:$ 37.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesAnimal ModelBiogenesisBiologicalBiomedical ResearchCell ProliferationCell TherapyCellsDataDiGeorge SyndromeDisease modelFutureGenesGenetic TranscriptionHumanImpairmentKnowledgeMaintenanceMediatingMicroRNAsMusOutcomePatientsPlayPluripotent Stem CellsProteinsPublic HealthRNARegenerative MedicineRegulationReportingResearchRodentRoleSmall RNASourceStem Cell ResearchTestingTherapeuticTissuesbasecrosslinking and immunoprecipitation sequencinggene regulatory networkgene repressionhuman diseasehuman modelhuman pluripotent stem cellhuman stem cellsimprovedinduced pluripotent stem cellinsightmouse modelnerve stem cellself-renewalstem cell differentiationstem cell therapystem cellstherapeutic miRNAtooltranscriptome sequencing
项目摘要
Project Summary/Abstract
Stem cells, including pluripotent stem cells (PSCs) and tissue-specific stem cells, can differentiate into
functional tissues and therefore serve as promising donor sources for cell-based therapies. Mouse models have
played indispensable roles in understanding the basic biological features and potential applications of stem cells.
However, because human and rodent have diverged from a common ancestral species over 85 million years
ago, it is not surprising that human stem cells also possess features that are not conserved in mouse cells.
Therefore, an improved understanding to the similarities and differences between human and mouse stem cells
is critical for using mice to model human diseases and test stem cell therapies. MicroRNAs (miRNAs) play a
central role in cell proliferation, differentiation, and survival. Mouse PSCs and neural stem cells (NSCs) deficient
for Dicer or Dgcr8, which encode factors essential for miRNA biogenesis, can self-renew but cannot differentiate,
demonstrating that miRNAs are not essential for self-renewal of these mouse cells. Because how miRNAs
regulate human stem cells have not been systematically investigated, whether similar miRNA regulation is
conserved across species remains unclear. In the preliminary studies, we generated DGCR8flox/flox human PSCs
(hPSCs), which enable DGCR8 inactivation in PSCs and the differentiated progeny. Our preliminary data showed
that, different from mouse cells, miRNAs are required for self-renewal of human PSCs and NSCs. Furthermore,
self-renewal is impaired in hPSCs with only one functional DGCR8 allele. Importantly, we identified that miR-302
or miR-92, when expressed alone, is sufficient to rescue self-renewal of DGCR8-/- human PSCs or NSCs,
respectively. Based on these data, we hypothesize that self-renewal of human PSCs and NSCs require miRNAs
such as miR-302 or miR-92, which differ fundamentally from the mouse stem cells. The rationale is that
knowledge on how miRNAs regulate human stem cells will improve our understanding to the differences between
human and mouse stem cells, which will allow recapitulation of human diseases in mouse models with greater
precision and make the mouse models more predictable, usable, and applicable for biomedical research. Aim 1
will compare how miR-302 regualtes human and mouse PSCs, Aim 2 will compare how miR-92 regulates human
and mouse NSCs, and Aim 3 will compare how heterozygous loss of DGCR8 affects human and mouse PSCs
and NSCs. The expected outcomes are to 1) discover the fundamental differences regarding to miRNA
regulation between human and mouse stem cells, which will be critical for the use of mouse models for stem cell
research and regenerative medicine applications; and 2) gain knowledge on how miRNAs regulate human stem
cells, which will serve as the basis for future comparison with stem cells from other animal models.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rui Zhao其他文献
Rui Zhao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 37.13万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 37.13万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 37.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 37.13万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 37.13万 - 项目类别:














{{item.name}}会员




